Medication info
Teneliel Duo Sustained Release Tablet 20/1000 mg

Teneliel Duo Sustained Release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
Pink oval-shaped sustained release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202719 · Approved 2022.07.01 · Insurance code 649702860

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication assists patients with Type 2 diabetes in managing their diet and exercise, helping them achieve more effective blood sugar control. The combined action of teneligliptin and metformin contributes to stabilizing blood sugar levels. Therefore, this medication is used to improve blood sugar management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is an oral anti-diabetic drug that helps control blood sugar. However, it should not be used in patients with poor kidney function or severe liver dysfunction. In particular, it should be temporarily discontinued before and after serious infections, trauma, or surgery, and can be resumed once kidney function returns to normal. Additionally, it is advisable for women who are pregnant or may become pregnant to avoid taking this medication. This drug can rarely cause a serious metabolic complication known as lactic acidosis, which is more likely to occur when there are conditions like reduced kidney function, cardiopulmonary disease, or sepsis. Therefore, patients should immediately inform their doctor if they experience symptoms of lactic acidosis, such as fatigue, muscle pain, difficulty breathing, or abdominal pain. The risk of hypoglycemia may increase when taking this medication with other anti-diabetic medications or insulin, so patients should be well aware of hypoglycemia symptoms and how to manage them. Caution is also advised for individuals engaged in high-risk activities, such as operating machinery or driving, due to the possibility of hypoglycemia or lactic acidosis. This medication may cause side effects such as gastrointestinal disturbances, headache, dizziness, or skin rashes; if any abnormal symptoms occur, patients should consult with their physician. Regular monitoring of kidney function and blood tests is important during treatment for any anomalies. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking during treatment. The effects of this medication on nursing infants are unknown, so nursing mothers should consult with healthcare professionals regarding whether to continue breastfeeding or discontinue treatment. The safety and efficacy of this medication in children has not been established, so it should not be used in pediatric patients. In the case of overdose, appropriate treatment should be obtained immediately at a hospital, and if kidney function is normal, the drug can be removed from the body via hemodialysis. Finally, this medication should be stored out of reach of children and should not be transferred to another container.

Side effects

Severe lactic acidosis, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, pseudo-pemphigus, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcers, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, increased ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium concentration, fatigue, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremors, headache, weakness, hunger, fatigue, facial swelling, dyspepsia, nausea, viral upper respiratory infection, cold sweat, pruritus, diabetic retinopathy, vision loss, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, cerebral infarction, hyperglycemia, uterine pus accumulation, nasopharyngitis, breast cancer, gastroenteritis, musculoskeletal chest pain, falls, animal bites, radial fracture, insomnia, hives, dizziness, iron deficiency anemia, food allergy, pressure ulcer, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, hearing loss, endolymphatic hydrops, atrial fibrillation, hypothyroidism, anxiety disorder due to general medical conditions, ovarian cyst, vulvar pruritus, menopausal symptoms, biliary obstruction, toxic hepatitis, chronic cholecystitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval-shaped sustained release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.